Kindstar Globalgene Technology, Inc. (HK:9960) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kindstar Globalgene Technology, Inc. has announced its intention to acquire 100% equity interest in two biotech companies, Guangzhou Kangcheng Weiye Biotechnology Co., Ltd. and AnchorDx Inc. These proposed acquisitions are currently in negotiation stages and have not yet resulted in any legally binding agreements. Shareholders and potential investors have been cautioned to exercise care when dealing in the company’s securities.
For further insights into HK:9960 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money